PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 March 2024, 08:00 a.m. CET
alfapump® – PMA1 submitted to US FDA and accepted for substantive review, extensive feedback...
REGULATED INFORMATION – INSIDE INFORMATION
Pending FDA approval, alfapump could become the first active implantable medical device in the US for treating liver ascites
Ghent,...
The healthcare industry is continuously evolving and innovative approaches are needed to address its challenges. Gamification, the integration of game-like elements in non-game contexts,...
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION19 October 2023, 07:00 am CEST One-year alfapump data from POSEIDON shows safety and strong efficacy profile is...
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION18 October 2023, 07:00 am CEST First two US patients from non-randomized cohort successfully treated with DSR 2.0...
--Must See--
Katalin Karikó and Drew Weissman, pioneers in the field of messenger RNA (mRNA) research, have been awarded the Nobel Prize in Medicine for...
COVID & Schools: Exploring New Variants, Vaccines, and Addressing Questions | A Presentation by the Community Funding AcceleratorIntroduction:The COVID-19 pandemic has significantly impacted various...
COVID & Schools: Exploring New Variants, Vaccines, and Addressing Common Questions | A Presentation by the Community Funding AcceleratorIntroduction:The COVID-19 pandemic has significantly impacted...
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to...
Ghent, Belgium – 6September2023– Sequana Medical NV(Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of fluid overload in liver disease,...
